2017 China Innovation and Entrepreneurship Competition – Intelligent Precision Medicine Special Event Kicks Off with Focus on AI and Big Data in Healthcare

On November 4, the 2017 China Innovation and Entrepreneurship Competition – Specialized Track on Intelligent Precision Medicine was officially launched at Shanghai Health Intelligence Valley. Leaders and guests from institutions such as the Torch High Technology Industry Development Center of the Ministry of Science and Technology and Meinian Onehealth Healthcare Industrial (Group) Co., Ltd. attended the launch ceremony and delivered remarks.

On that day, nearly 100 startups and teams engaged in fierce competition during the semifinals, with eight companies and six teams ultimately advancing to the finals. Activities such as “Matchmaking with Large Enterprises” and “Keynote Speeches” provided participating representatives with in-depth networking and knowledge-sharing opportunities, facilitating their entry into the greater health ecosystem.

Health is an essential requirement for promoting comprehensive human development, a fundamental condition for economic and social progress, and a shared aspiration of the general public. Following the successful conclusion of the 19th National Congress of the Communist Party of China, the Intelligent Precision Medicine Professional Competition was launched as scheduled at Shanghai Health Intelligence Valley.

On that day,Nearly 100 projectsRepresentatives from across China have gathered here to jointly explore and share the “integration pathways” of artificial intelligence and precision medicine in the new era.The rapid development of global big data and artificial intelligence will also usher in a new era of smart healthcare.

Live Updates

In the future, big data will play a pivotal role across the entire health industry. Whether in primary prevention, disease risk assessment, genetic screening, or intelligent diagnosis, big data will drive innovative models that transform traditional approaches.With the extensive accumulation of health data, the intelligent and precise transformation of healthcare has become a major trend.

As the organizer of this professional competition, Meinian Onehealth leverages its vast data accumulated from its core health examination services and its pivotal position within the closed-loop health industry ecosystem to serve as a key entry point for startups into the health sector. Through the competition platform, participating projects across China will converge at Meinian Onehealth’s startup incubation platform, Health Intelligence Valley (Jiankang Zhigu). In the subsequent stages of the competition and thereafter, these projects will establish connections with entrepreneurial enterprises and teams to foster deeper collaboration and exchange. Within this “super incubator” for the medical and health industry, entrepreneurs will be provided with data resources, traffic support, capital access, as well as corresponding startup guidance and assistance.

Yu Rong, Chairman of Meinian Onehealth Healthcare Industry (Group) Co., Ltd.

At the launch ceremony, Yu Rong, Chairman of Meinian Onehealth Healthcare Industrial (Group) Co., Ltd., delivered a speech.

Yu Rong stated, “The China Innovation and Entrepreneurship Competition is the premier national-level contest in China, representing the highest standard of mass entrepreneurship and innovation across the country, with the broadest influence and appeal. In alignment with the national trend of technological innovation in precision medicine, and guided by General Secretary Xi Jinping’s directives on the future development of the healthcare industry delivered at last year’s National Health Conference and in his report to the 19th National Congress of the Communist Party of China, the inaugural Intelligent Precision Medicine Specialized Competition was launched.”

“Healthcare is one of the key pillar industries supporting China’s future transformation and development, while big data and artificial intelligence serve as critical drivers and vehicles for China’s next wave of innovation competitiveness to catch up with advanced international standards. The integration of health and intelligence, healthcare and intelligence, as well as precision medicine and big data, will be the central themes for entrepreneurship and innovation in China’s future healthcare sector.”

As one of the organizers, Yu Rong also stated, “Meinian Onehealth Healthcare serves as a gateway to medical demand for tens of millions of individuals, providing professional health check-up services to tens of millions of Chinese people annually. It has thus become a crucial incubation hub for the industry. Supported by such big data and channel resources, a number of precision medicine startups have been nurtured. Wandong Medical, as another organizer, is a leader and dominant enterprise in the field of medical imaging, with a solid foundation and significant influence in key areas such as artificial intelligence, medical imaging, and telemedicine.”We will provide comprehensive support in terms of capital, industry resources, and funding, with the aim of fostering a cohort of leading enterprises with global influence through this professional competition.”

Nearly 100 healthcare and medical projects from across China have converged in Shanghai, remaining steadfast in their original entrepreneurial commitment to realizing the “Healthy China” initiative. This shared vision enables them to maintain a holistic perspective in project operations, steer development direction, and sustain momentum for progress.

# Contestant Registration

The continuous “penetration and integration” of big data and artificial intelligence in the healthcare sector will reshape the ecosystem of the health industry. Projects featuring integrated innovation in areas such as virtual assistants, risk diagnosis and prediction, medical imaging, hospital management, smart devices, new drug development, health management, and genetic testing have become part of the Professional Competition on Intelligent Precision Medicine.Focus。

At the kickoff meeting, Wang Zheng from the Organizing Committee Office of the China Innovation and Entrepreneurship Competition presided over the grouping for the semi-finals, dividing the participating projects into4 Corporate Groups and 1 Team Group, with each group evaluated by a panel of three judges. The top two teams from the corporate category and the top six teams from the team category will advance to the finals.

Wang Zheng, Office of the Organizing Committee of China Innovation and Entrepreneurship Competition

Semi-Final Venue

Under Review by Judges

That afternoon, the competing projects took the stage one after another for their “roadshows” in the semi-finals. Among them, the project from Heilongjiang, “Tuomeng Technology”, is a high-tech enterprise engaged in the research, development, and application of 3D reconstruction for medical imaging and 3D printing technologies. The company already won honors in the finals of the Internet and Mobile Internet Industry category at the 5th Competition, and will once again “compete” with its peers in the field of precision medicine. This enterprise can provide comprehensive personalized and precision medicine solutions, and is the first company in China to advocate and implement a complete set of solutions for medical 3D printing.

To strengthen the clinical translation and scientific research of medical 3D printing technology, the company has collaborated with multiple large general and specialized hospitals in China to jointly establish Clinical Application and Research Centers for Medical 3D Printing Technology, providing customized software development for hospital departments.

There are also “Huidu Medical”, the company is an international high-tech enterprise focused on early cancer screening and personalized medicine. Its team members hail from top-tier industry and academic institutions worldwide, and it has developed a second-generation liquid biopsy technology based on combined RNA and DNA detection. Jia Shidong, the company’s CEO, stated in a media interview: “Eastern medicine is like observing patients through a telescope, while Western medicine is like examining them under a microscope. Precision medicine requires integrating the profound wisdom of the East with the precise, quantitative science of the West, achieving a combination of depth and breadth between medicine and philosophy.”

“Huidu Medical” adheres to the professional standard that “the starting point is the industry pinnacle.” From its inception, the company has been positioned to address clinically significant problems that currently lack effective solutions, particularly focusing on common cancers in China. By leveraging next-generation sequencing (NGS) to precisely detect gene variants on trace amounts of cell-free RNA (cfRNA) and cell-free DNA (cfDNA) in the blood, this project achieves combined molecular detection at both the cancer DNA genomic and RNA transcriptomic levels. This technology overcomes the current limitation of liquid biopsies being restricted to DNA analysis, enabling a true “comprehensive liquid biopsy” and offering new hope to clinical cancer patients. This mission represents the original aspiration behind the founding of “Huidu Medical.”The project successfully advanced in first place within its group.

There are also “Smart Healthcare Explorer“The team participated in this professional competition with a mindset geared toward learning, experiencing, and exchanging ideas. Their project is a mobile-based intelligent PACS system, a novel concept that streamlines and simplifies traditional PACS.”

This system was co-developed with Xi’an Honghui Hospital, enabling physicians to seamlessly access and view standardized DICOM data stored in the system directly via mobile devices, offering exceptional operational convenience. Patients need only upload medical images on the PC end, allowing physicians to provide image interpretation and advisory services via either mobile or PC platforms.

In the initial phase, the project’s mobile platform will be accessible via Alipay Mini Programs and WeChat Official Accounts. Once the system matures, the team will integrate its deep learning–medical healthcare innovations into the platform, leveraging deep learning technologies to enable services such as automated image interpretation, thereby realizing a truly intelligent mobile PACS system.

Ultimately,8 Enterprises and 6 TeamsSuccessfully breaking through, they will take the stage in the finals of this professional competition.

Hangzhou Miaoshou Robotics Co., Ltd.

Hangzhou Shukang Medical Technology Co., Ltd.

Shanghai Anqing Medical Device Co., Ltd.

BasePoint Biotech (Shanghai) Co., Ltd.

Huidu (Shanghai) Medical Technology Co., Ltd.

Nanjing Fuyi Technology Development Co., Ltd.

Jiangsu Zecheng Biotechnology Co., Ltd.

Xiamen Aode Biotechnology Co., Ltd.

EdiGene Precision Gene Editing Therapy Project Team for Thalassemia

TCM-GO

Wings of Light

Miantian Technology Team

Kamai Jinmei Biomedical Team

Wuxi Tongkang Medical Device Team

On that day,Sun Tong, General Manager of the Procurement Department at Meinian Onehealth Healthcare Industry (Group) Co., Ltd.; Ren Zhilin, Director of Beijing Wandong Medical Technology Co., Ltd.Li Zhengyan, Director of the Institute of Intelligent Technology at Shanghai Haier Medical Technology Co., Ltd., presented innovation needs generated within the group and engaged in in-depth exchanges with the contestants. Beijing Kechuang Jiayi Technology Service Co., Ltd. (Chuangdongli) will continue to follow up on the matchmaking between participating enterprises and large corporations in the future and provide corresponding services.

Among them, Sun Tong stated that Meinian Onehealth has an extensive strategic plan encompassing customer characteristics, disease attributes, technological innovations, and application scenarios. Starting from the health checkup entry point, subsequent health interventions and treatments, disease diagnosis, and mobile healthcare are all included in its development roadmap.

In his keynote address, Liao Jieyuan, founder of WeDoctor Group, presented on “From Single-Point Breakthroughs to Business Synergy” as the theme. He stated that entrepreneurship is a process of continuous innovation.The convergence of pain points, policies, and technology can create rare entrepreneurial opportunities.Startups must first achieve a breakthrough at a single point by addressing a specific pain point or desire. Next, they should concentrate all efforts on this focal area to transform initial weaknesses into an absolute competitive advantage. Finally, with talent as the foundation, they should expand into related business areas, deepening their involvement layer by layer to create business synergies.

Subsequently, Wang Xiaojun, General Manager of Health Intelligence Valley, delivered a speech titled “Incubation of the Big Health Industry within an Ecosystem” as the topic.

The Grand Finals of the 2017 China Innovation and Entrepreneurship Competition – Intelligent Precision Medicine Category will be held tomorrow (November 5). You are warmly invited to attend and witness the crowning of the National Champion in the intelligent precision medicine industry.

Finals Time: November 5, 9:00–16:00

Finals Venue: Health Intelligence Valley, Jing'an District, Shanghai

This professional competition was guided by the Office of the Organizing Committee of China Innovation and Entrepreneurship Competition, jointly supported by the Shanghai Municipal Science and Technology Commission, the Shanghai Municipal Health and Family Planning Commission, and the People’s Government of Jing’an District, Shanghai. It was co-hosted by Meinian Onehealth Healthcare Industry (Group) Co., Ltd. and Beijing Wandong Medical Technology Co., Ltd., co-organized by Beijing Kechuang Jiayi Technology Service Co., Ltd., Beijing Tianyi Hongfang Investment Management Co., Ltd. (Health Intelligence Valley), and Mei Yin Health Technology (Beijing) Co., Ltd., and co-sponsored by China Development Bank Technology Venture Capital Co., Ltd., Shanghai Zhongwei Venture Capital Management Co., Ltd., and Beijing Fangsheng Investment Management Center (Limited Partnership).